ViAqua
Categories
Founded
2014
Leadership
- Shai Ufaz, PhD, Co-Founder and CEO
Headquarters
Haifa, Israel
Website
S2G North Star Interim Outcomes
- Increased demand for healthier and sustainable seafood
- Increased uptake of solutions, products, and technologies that enhance productivity of blue economy
ViAqua is a developer of an RNA-particle platform to promote and improve animal health in aquaculture.
ViAqua Therapeutics was established to address the growing need for effective, specific, and affordable health management of diseases in aquaculture. ViAqua is developing a biotechnology-based, oral delivery platform for targeted administration of nucleic acid-based therapeutics. ViAqua’s first product is an RNA-based solution for application against the White Spot Shrimp Virus (WSSV) pandemic.
